Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biomolecules|November 27, 2021
p53-Mediated Radiosensitization of 177Lu-DOTATATE in Neuroblastoma Tumor SpheroidsSara Lundsten, Hanna Berglund, Preeti Jha, et al.
Thyroid Research|October 2, 2025
CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapyAdam Stenman, Joachim N Nilsson, Vincenzo Condello, et al.
Acta Biomaterialia|September 30, 2018
Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6Patrick J Kennedy, Flavia Sousa, Daniel Ferreira, et al.
Journal of Photochemistry and Photobiology. B, Biology|May 1, 2023
Photoactive immunoconjugates for targeted photodynamic therapy of cancerSara R G Fernandes, Tabassom Mohajershojai, Sara Lundsten, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 10, 2007
Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassayMarika Nestor, Tomas Ekberg, John Dring, et al.
Frontiers in Oncology|September 24, 2019
Exploring Radiation Response in Two Head and Neck Squamous Carcinoma Cell Lines Through Metabolic ProfilingEva Lindell Jonsson, Ida Erngren, Mikael Engskog, et al.
Nanomaterials (Basel, Switzerland)|April 25, 2020
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized LipodisksSara Lundsten, Víctor Agmo Hernández, Lars Gedda, et al.
Frontiers in Oncology|October 5, 2020
The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer ModelDiana Spiegelberg, Anja Charlotte Lundgren Mortensen, Kartika Dyah Palupi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
[177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination StrategiesAmanda Gustafsson, Hedvig Svedberg, Sara S Rinne, et al.
Scientific Reports|December 29, 2022
Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapyXin Yu Koh, Xiao Hui Koh, Diana Spiegelberg, et al.
Pageof 7